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The aim of this study was to assess the potential protective effect of zinc chloride (ZnCl 2 ) as an antioxidant against the cytotoxic and mutagenic effects induced by yclophosphamide (chemotherapeutic agent), using mutagenicity tests; molecular assay, chromosomal aberrations (CA), and Mitotic index (MI) in vivo as the biomarkers. The experiment was designed as four groups (6 rats per group). Group 1 was injected intraperitoneally (i.p.) with saline solution (1 ml/kg body weight) every other day for 20 days and served as (control group). Group 2 (the treated group) was injected i.p. with a single dose of CP (200 mg/kg b. w.). Group 3 was injected i.p. with a single dose of CP (200 mg/kg b. w.) and treated simultaneous by ZnCl 2 (4 mg/kg b. w.) every other day for 20 days, while group 4 (the protective group) was pretreated with ZnCl 2 (4 mg/kg b. w.) every other day for 20 days, then treated with a single dose of CP (200 mg/kg b. w.) on the 21st day and was left. The experiment extended for 45 days after the treatment with the cyclophosphamide dose. The results revealed changes in the number, position, and intensity of DNA fragments for liver and kidney tissues in the treated rats with cyclophosphamide, in addition to significant decline in mitotic index and increase in the frequency of chromosomal aberrations compared with the control group. These results may be attributed to the fact that cyclophosphamide can induce genotoxicity through DNA damage in healthy cells. In comparison, rats that were treated simultaneous and pretreated with zinc chloride and then treated with a single dose of cyclophosphamide showed marked improvement in DNA fragments, decrease in the frequency of chromosomal aberration, and an elevation in mitotic index. Furthermore, pretreatment with zinc chloride revealed more protective role in mitotic index and reduce markedly DNA damage and chromosomal aberrations that induced by cyclophosphamide than those showed with the treatment with zinc chloride simultaneity with Cp treatment. Pretreatment of Zinc chloride may open an interesting field concerning its possible use in medicine applications, as a protective treatment to reduce the side effects that can occur by cyclophosphamide treatment and other chemotherapeutic agents.
INTRODUCTION
Cyclophosphamide (CP) is an effective anti-cancer alkylating agent, on the other hand it possesses cytotoxic effects towards normal cells (Kim et al., 2013) .
CP can destroy the normal antioxidant system by active metabolites represented in phosphoramide mustard and acrolein resulting in the accumulation of reactive oxygen species, that can cause DNA damage. Several previous studies reported that cyclophosphamide has carcinogenic effects in healthy human and animal tissues (Rehman et al., 2012) , it causes gene mutations, chromosomal aberrations in mice tissues in vivo and in vitro test systems, and an elevated frequency of secondary treatment-related tumors in human cancer survivors (Ember et al., 1995; Ridder et al., 1998; Sundramoorthy et al., 2004; Kruawanand et al., 2006) . Numerous studies using the Chromosome aberration (CA) and Mitotic index (MI) in vivo and in vitro as the biomarkers reported that treatment with cyclophosphamide can induce cytotoxic and mutagenic effects in bon marrow cells of rat and rabbit (Popov et al., 2011; Sharma et al., 2012; Sharma V. and Agrawal 2015; Sushma et al., 2015; Koura et al., 2017) . Therefore, it is necessary to develop antioxidant materials to reduce the side effects of CP and the other chemotherapeutics.
Zinc is an essential metal that is integral to many enzymes and transcription factors in the cell. Ii plays an important role in protecting DNA and other cellular components from oxidation and damage through its participating in vital processes such as transcription and replication of DNA through zinc finger proteins (Levine, 1997; Powell, 2000; Prasad, 2003; Ho, 2004; Emily, 2004; Ebisch et al., 2007; Leoni et al., 2014) . DNA transcription is a main part of germ cell development, therefore zinc is affecting important biological processes such as cell division, growth, and differentiation; and it maintains DNA strand from damage (Badkoobeh et al., 2013; Grüngreiff 2016) .
Other studies (Satoh et al., 1993; Sandstrom et al., 1994; Lindahl et al., 1998; Noh and Koh, 2000; Dhawan and Chadha, 2010; Maremanda, et al., 2014) suggest that zinc has a role as an anticancer and its treatment increases resistance against the tumor in mice, thus it has a potential effect on apoptosis. Estı´baliz et al., (2003) reported that pretreatment with zinc showed modulate in DNA damage and gave results near the control levels. For this, in the present study, rats were exposed to ZnCl 2 pre and simultaneous treatment via intraperitoneal injection, followed by the injection with cyclophosphamide to evaluate the protective effects of ZnCl 2 on DNA fragments in liver and kidney tissues by using inter simple sequence repeat (ISSR) markers. To obtain more effective results, the author assessed the mitotic index and chromosome aberrations using bone marrow cells analysis of the tested rats.
MATERIALS AND METHODS

1-Chemical Materials: Cyclophosphamide (CP):
Cyclophosphamide was supplied as vials from Baxter Oncology, Germany.
Zinc Chloride (ZnCl 2 ):
ZnCl 2 salt from El-Nasr Pharmaceutical Chemical Co.
Primers:
Five ISSR primers were used in the detection of polymorphism among the liver and kidney tissues of tested rat groups. These primers were synthesized by Metabion Corp Germany.
Experimental Animals:
Twenty four of male albino rats of approximate weight (20-25 g) were obtained from the animal house of Veterinary College, south valley university. The rats were housed in the animal house of the science college, South Valley University, Qena, under normal conditions with a balanced diet and water ad libitum until the weight of rats reached of (200-250 g).
Experimental Design:
When the rats reached from 200 to 250 g, 24 rats were divided randomly into 4 groups of 6 rats each. Group 1: This group is (control group), each rat of this group was injected intraperitoneally with saline solution (0.9 % NaCl, 1 ml/kg b. w.) every other day for 20 days. Three rats of each group were dissected to obtain DNA from liver and kidney tissues according to (Zietkiewicz et al., 1994) . DNA concentration was determined by diluting the DNA 1:5 in dH2O. 10 µg of a DNA size marker (Lambda DNA digested with HindIII and Phi x 174 DNA digested with HaeIII). This marker can cover from 310 bp to 23130 bp of DNA fragments size, and a range of concentration from 11 ng to 95 ng. Thus, estimation of the DNA concentration in a given sample was achieved by comparing the degree of fluorescence of the unknown DNA band with the different bands in the DNA size marker.
b-ISSR Reaction:
PCR amplification reactions were carried out as described by (SharafEldeen et al., 2006) . Reactions in PCR system were performed in 25 µl volume that composed of (1x reaction buffer, 0.2 mM of dNTPs, 1.5 mM MgCl 2 , 0.2 µM of primer, 0.5 unit of Taq polymerase, and 50 ng of template DNA). The temperature profile in the different cycles was as follows: an initial strand separation cycle at 94°C for 5 min followed by 40 cycles comprised of a denaturation step at 94°C for 1 min, an annealing step at 45°C for 1 min, and an extension step at 72°C for 1.5 min. The final cycle was a polymerization cycle for 7 min at 72°C.
c-Electrophoresis Analysis:
PCR products were mixed with 5 µl gel loading dye and resolved by electrophoresis in a 1.5% agarose gel containing ethidium bromide (0.5 mg/ml) in 1 x TBE buffer at 120 volts. A 100 bp DNA ladder was used as molecular size standard. PCR products were visualized under UV light and documented using a ™XR+ Gel Documentation System (BioRad).
Cytogenetic Studies: a-Chromosomal Preparations:
After the end of the determined period of the experiment, three rats from each group were injected intraperitoneally with 0.05% colchicine, for 2.5 h. before sacrifice. Bone marrow preparations for the analysis of metaphase cells were obtained as described by Yosida et al., (1977) with some modifications. 200 metaphase spreads per tested group were screened to determine the number and types of chromosomal aberrations per group.
b-Statistical Analysis:
Number of chromosomal aberrations was expressed as means ± SE. 200 metaphases were counted for three rats in each group. Statistical analysis of cytogenetic was performed on SPSS software (version 24). P values were less than 0.05 levels (P < 0.05) were considered to be significant.
c-Calculation of Mitotic Index:
Form mitotic division stages about 5000 cells counted for each animal. Mitotic index was calculated according to the formula that described by Singh and Sankhla (2010) . Mitotic index= A/A+B Where A= No. of dividing bon marrow cells (metaphase) B= No. of non dividing bon marrow cells
RESULTS
a-The Molecular Genetic Results:
Inter simple sequence repeats (ISSRs) analysis was performed to evaluate the protective effects of pre and simultaneous treatment with zinc chloride against Cyclophosphamideinduced genotoxicity in rat tissues. Farther, the comparison between the effect of pretreatment and the simultaneity treatment of zinc chloride on cyclophosphamide against its genotoxicity. Two tissues (liver and kidney) of male albino rats were used to obtain DNA. The results of each treated group were examined through inter simple sequence marker in comparison with the control group. Data were illustrated for five primers in (Figures 1  and 2 ). These primers that used consist of different di-and tri-nucleotide repeats to determine the genetic variation among the tested groups as well as possible (Table 1 ). The molecular size of amplified bands in liver and kidney were illustrated in (Table 2) . Table ( The results from liver tissue: the five primers (primer ISSR-1, ISSR-2, ISSR-3, ISSR-4, and ISSR-5) were generated 11, 15, 14, 17, and 8 bands, respectively, with an average 13 bands per primer. The five primers developed a total of 209 bands in which 76 of them were polymorphic bands (36.4% polymorphism) as shown in (Figure 1 ). All the five primers produced polymorphic bands by different percentage, 36.4 %, 62.5 %, 64.3 %, 52.9%, and 25.0% polymorphism (primer ISSR-1, ISSR-2, ISSR-3, ISSR-4, and ISSR-5), respectively ( Table 3) . The results showed also that all treated groups of rats had disappeared or appeared new bands compared with control group. Control group generated 57 ISSR bands with the five primers opposite to 43, 53, and 57 bands for groups 2, 3, and 4, respectively (Table 2 ). These results revealed that the number of lost bands in group 2 and 3 was obviously higher than the number of new bands compared with the control group. Animals treated with cyclophosphamide (group 2) showed the highest lost bands (the total bands was 43 compared to 57 for control group). Thus, group 2 could be an obvious indication for the high genotoxic effect of cyclophosphamide due to losses of alleles compared with the groups that treated by cyclophosphamide plus zinc chloride, groups 3 (52 bands) and 4 (57 bands). Rats in group 3 and 4 with simultaneity and pretreatment with zinc Chloride every other day for 20 days respectively, and followed by treated with CP, showed improvement in DNA strand and increase in bands number (52 and 57 bands, respectively) compared with group 2 (43 bands) that was treated with CP only. These results suggested that the animals treated with cyclophosphamide and received zinc chloride had less genotoxic effect than those treated with cyclophosphamide only, and zinc chloride pretreatment (group 4) exhibited more protective that lead to better result than simultaneity treatment in group 3 compared to the control. (Figure 2 ). All primers produced polymorphic bands with less percentage compared to liver tissue, 18.2 %, 33.3 %, 45.5 %, 20.0%, and 42.9 % (primer ISSR-1, ISSR-2, ISSR-3, ISSR-4, and ISSR-5), respectively (Table 3) . Treated groups had disappeared or appeared new bands also compared with control group (Fig.  2) . In control group, 50 ISSR bands were obtained opposite to 44, 46, and 47 bands for groups 2, 3, and 4, respectively (Table 2) . Results revealed also, the lost bands in treated groups were more than the new generated bands compared with control group. Rats treated with cyclophosphamide (group 2) showed the highest lost bands (the total bands was 44 compared to 50 for control group), which could be an obvious indication for the genotoxic effect of cyclophosphamide in renal tissue due to losses of alleles. Rats in groups 3 and 4 that were treated with doses of zinc chloride every other day for 20 days simultaneitly and pretreatment, respectively, and followed by a single dose of cyclophosphamide, showed increase in the number of bands (46 and 47) bands, respectively, compared with Cp treated group (44 bands). These results suggested that the rats treated with zinc chloride and received cyclophosphamide showed less genotoxic effect in renal tissue than those treated with cyclophosphamide only.
Moreover, the present results showed that liver tissue is more sensitive to toxic actions for CP than kidney tissue. In group 2 (The treated group by cyclophosphamid) liver tissue generated 43 bands, 22 of them were polymorphic bands with percentage 51.2%, while kidney tissue generated 44 bands, 11 of them polymorphic bands with 25% percentage.
These results of polymorphism were improved in liver tissue under the effect of zinc chloride to 11.5% and 10.5% in simultaneous and pretreatment treatment with CP (group 3 and 4), respectively. In kidney tissue, the results were improved to 10.9% and 6.4% in group 3 and 4, respectively (Table 4) .
Overall, the present study demonstrated that both the pre and the simultaneous treatment with ZnCl2 have a protective role against CP-induced genotoxicity in liver and kidney tissues. This protection was more effective in pretreated rat group with ZnCl 2 for 20 days before treated with CP compared to this treated simultaneously with ZnCl 2 and CP as shown in Figure 4 that demonstrated the relationships among tested rat groups and control group in liver and kidney tissues. Consequently, pretreatment with ZnCl 2 may be applied as a protective agent for people in need of treatment by cyclophosphamide. The antimutagenic potential of zinc chloride against cyclophosphamide genotoxicity was evaluated using in vivo assays of rat bone marrow cells. Doses of 4 mg/kg of zinc chloride every other day for 20 days was tested in pre and simultaneously treatment with a single dose of cyclophosphamide compared with the control group and treatment group with CP only. It was observed that in rats administered with cyclophosphamide there was a significant increase in the number of chromosomal aberrations and a decline in mitotic index as compared to the control group. In rats that simultaneous or pretreated with zinc chloride, and followed by administered cyclophosphamide, the number of chromosomal aberrations were less and the mitotic index was nearly equivalent to the control group (Table 5&6 and Figure 3 ). (Haubitz, 2007) . It induce a variety of changes in DNA, that can cause secondary tumors in human and animal healthy tissues (Krishna et al., 1987; Ember et al., 1995; Ridder et al., 1998; Codrington et al., 2004) . Murata et al., (2004) reported that CP and its metabolites induce oxidative stress and react with electron rich areas such as nucleic acids and proteins. Therefore, CP causes disruption of cell growth, mitotic activity, and functions via alkylation of DNA at the N7 position of guanine. Chromosomal aberrations are due to DNA damage caused by phosphoramide mustard which leads to break down of the DNA strand (Sharma et al., 2012) . The present study demonstrated that the treatment of rats with a single dose of cyclophosphamide caused DNA damage in liver and kidney tissues, as well as decline in mitotic index and increase in the frequency of the chromosomal aberrations in bon marrow cells, these results of the present study are in agreement with all pervious studies.
Numerous studies such as (Murata et al., 2004; Abdella, 2008; Sowjanya et al., 2009; Popov et al., 2011; Sharma et al., 2012; Ch and Devi, 2015; Sharma and Agrawa, 2015; Kour et al., 2017) found that Bone marrow analysis technique of rat revealed clear signs of genotoxicity. Several changes in DNA damage, chromosomal aberrations, Sister Chromatide Exchanges, and decrease in mitotic index after intraperitonealy injection of cyclophosphamide. These reports are in agreement with present study that revealed DNA damage and decrease in the DNA bands, decline in the mitotic index, and the occurrence of chromosomal aberrations such as fragmentation, chromosomal ring, chromatid deletions, and dicentric chromosomes in the treated group with CP only. Abdella (2012) reported that despite that most chemotherapy include CP and are necessity for killing cancer cells, they have undesirable toxicity to normal tissues, where CP treatment has the ability to produce chromosome aberrations and decline in mitotic index in animals, current search results may be involved in solving this problem.
Over all, Cyclophosphamide belong to a class of drugs known as alkylating agent, which have been used to treat some kind of cancer, several studies confirmed that it is a potent anticancer drug but it also affects normal cell division by decreasing the immune responses. The present results indicated that albino rats treated with single dose of CP and left for 45 days showed several times increase in frequency of chromosome aberrations and decrease in the mitotic index. This results are in agreement with the previous investigations which confirmed that CP had the side effects as oxidation and genotoxic effects in normal tissues of treated animals. Therefore, the developing of anti-cancer drug or manufacturing new drugs with low or no side effects has become an important aim in modern studies to overcome chemotherapeutic side effects.
Zinc is a component of chromatin structure, integral in DNA replication and transcription. Thus, zinc is involved in protecting cell and its components against oxidative material and preserving DNA, regulation of transcription, and replication of DNA through zinc finger proteins ( Pavletich et al., 1993; Falchuk, 1998; Dong et al., 1999; Ho, 2003; Emily, et al., 2004; Witkiewicz-Kucharczyk and Bal, 2006; Song et al., 2009; Dhawan and Chadha, 2010) . Many studies reported that zinc salts have the ability defend against oxidative harm to the different tissues (Sunderman, 1995; Bagchi et al., 1998; Zago and Oteiza, 2001; Badkoobeh et al., 2013) .
Other studies reported that Zn supplementation in rats reduced and ameliorated various types of CP-induced DNA damage (Ishida, 2017; Torabi et al., 2017) , and inhibit apoptosis induced by chemotherapeutic agents (Maremanda et al., 2014; Ghobadi et al., 2017) . In the present study, doses of (4 mg /kg b. w.) of zinc chloride simultaneous and pretreatment associated with cyclophosphamide exposure, clearly reduced DNA damage, chromosomal aberrations, and elevated of mitotic index. These results indicate zinc chloride has provided protection against cyclophosphamide induced cytotoxicity using various cell lines in vivo assay that are in agreement with the previous findings. ( Garufi et al., 2015) reported ZnCl 2 could be a valuable element in chemotherapeutic against cancer and reduce the side effects of these drugs. This reports also are agree with the obtained results of the present study that showed DNA fragments, mitotic index, and chromosomal aberrations together indicate the best protective effect of zinc chloride especially in pretreatment against CP induced genotoxicity in rat tissues.
CONCLUSION:
The present data indicated that the pretreatment by zinc chloride or simultaneous treatment have good antimutangenic activity against cyclophosphamide induced genotoxicity, zinc being antioxidant or acting on DNA replication, resulting in increase in DNA fragments, significant inhibition in the formation of chromosomal aberrations, and elevation in mitotic index that induced by the treatment with cyclophosphamide. Furthermore, pretreatment with zinc chloride showed more protective effects in all tested rat tissues (liver, kidney, and bon marrow) as well as elevation in mitotic index than simultaneous treatment compared to the treatment with cyclophosphamide alone. The present results have demonstrated the capability of zinc chloride, as an essential element in the healthy body, and its ability to maintain the normality of DNA fragment and the bone marrow cells in cyclophosphamide-treated rat tissues. Over all, it appears that ZnCl 2 is a potential antioxidant as an additive to chemotherapeutic drugs that are toxic to human organs. Present findings indicate favorable prospects for clinical applications for zinc chloride in combination with chemotherapeutic agents like CP. 
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